Adicet Bio, Inc. - Common Stock (ACET)

Adicet Bio Inc. is a biotechnology company focused on developing innovative cell therapies for cancer and other diseases

The company specializes in utilizing its proprietary technology to engineer immune cells, particularly gamma delta T cells, to effectively target and eradicate tumor cells. By harnessing the body's immune system, Adicet aims to create next-generation therapeutic solutions that can provide patients with more effective and personalized treatments, thereby advancing the field of immunotherapy and improving outcomes in oncology.